Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Movement Disorders : Official Journal of the Movement Disorder Society|September 22, 2020
Introduction of a Management Toolkit for Lewy Body Dementia: A Pilot Cluster-Randomized TrialJohn T O'Brien, Ian G McKeith, Alan J Thomas, et al.
NPJ Parkinson'S Disease|November 21, 2017
Erratum: Author Correction: Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's diseaseRashmi Lakshminarayana, Duolao Wang, David Burn, et al.
NPJ Parkinson'S Disease|June 27, 2017
Using a smartphone-based self-management platform to support medication adherence and clinical consultation in Parkinson's diseaseRashmi Lakshminarayana, Duolao Wang, David Burn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 15, 2022
Neuromelanin-MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template-Based Standardized AnalysisYue Xing, Abdul Halim Sapuan, Antonio Martín-Bastida, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2007
Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task forceBruno Dubois, David Burn, Christopher Goetz, et al.
Clinical Pharmacology and Therapeutics|September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsMalidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Neuroepidemiology|November 3, 2015
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PDStefanie Lerche, Inga Liepelt-Scarfone, Guido Alves, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 2, 2009
Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECTVicky L Marshall, Cornelia B Reininger, Moritz Marquardt, et al.
Frontiers in Aging Neuroscience|July 23, 2016
Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons LearnedSebastian Heinzel, Benjamin Roeben, Yoav Ben-Shlomo, et al.
Plos One|May 19, 2017
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson diseaseChelsea Caspell-Garcia, Tanya Simuni, Duygu Tosun-Turgut, et al.
Pageof 8